CONTENTS

Summer 2024

Discovery and development

Image
14. How public/private partnerships in genomics are streamlining patient pathways and delivering value

Since the completion of the Human Genome Project in 2003, there has been huge growth in the utilisation of genomics, but how can partnerships in this area be used to improve patient experience
Image
Image
20. Next-generation size selection: accelerating the pace of gene synthesis in drug discovery and development

Synthetic biology has been a cornerstone in recent health advancements, including drug discovery, development and manufacturing, however there are challenges facing this market

Digital

29. Innovation can play a key role in Scotland’s fight to reduce ‘pandemic of frailty’

Frailty should not be considered an inevitability, but the effects can be significant. How can technological innovations combat this?

Manufacturing

36. Protein-based immunotherapies – the journey from discovery to manufacturing

Protein-based immunotherapies are reshaping oncology treatments, but ensuring their safety and efficacy is crucial for their success
42. Addressing the UK Government's new initiative on medical device equity

Medical devices should be designed with an awareness of the challenges around a specific disease as well as an awareness of equality, but how will this impact medical device production going forward?
44. The role of protein synthesis in drug discovery and development

How can protein synthesis be used within the discovery and manufacturing of new drugs and how can it be automated?

Lab automation

48. The journey to full automation – for labs of all sizes

With the lab of the future becoming increasingly automated, how will this change workflows and how can the industry prepare for this?

Microscopy

18. elmi2024: Thanks to all our attendees and sponsors!

RMS reflects on a fantastic week in Liverpool

Features

8. The key to formulation development is in the details

How can a thorough approach to tablet manufacturing reduce manufacturing issues, costs and downtime?
12. ACHEMA 2024 sets the tone for a more sustainable and competitive process industry

ACHEMA 2024 took place 10-14 June 2024 in Frankfurt, Germany, with 2,842 exhibitors from 56 nations
23. 17th European Microscopy Congress to take place in Copenhagen, Denmark

EMC2024 is the 17th European Microscopy Congress, taking place in Copenhagen, Denmark from Sunday 25 August to Friday 30 August
34. Ilmac Lausanne 2024 – The largest meeting place of the chemical and life sciences industry in French-speaking Switzerland

On 18 and 19 September 2024, Ilmac will be held at the Expo Beaulieu Lausanne, Switzerland

Regulars

6. Editorial desk

This issue brings you the latest innovations in the field of pharma, from AI to medtech and genomics
54. Events

IPT's
events page shows off some of the most exciting events this summer season has to offer

Index of Advertisers

IFC. RMS



17. EMC

31. ELRIG

33. ILMAC








OBC. Natoli
EXECUTIVE DIRECTOR 
PMGroup Worldwide Ltd
Karl Equi

GROUP MANAGING EDITOR
PMGroup Worldwide Ltd
Iona Everson

EDITOR
Charlie Blackie-Kelly

DEPUTY EDITORS
James Spargo
Natalia Elliot

EDITORIAL ASSISTANTS
Betsy Goodfellow

SALES
Louise Wilson-English

DESIGN
Peter May

FRONT COVER
Shutterstock

DIGITAL EDITION
IPT Online
www.iptonline.com

CONTACT US
Tel: +44 (0)20 7724 3456

PRINTING
Pureprint Group
www.pureprint.com
SUBSCRIPTIONS AND DATA
Curwood CMS Ltd
Unit 9 Barns & Stables,
Timworth Green,
IP31 1HS
c-cms.com
Tel: 01580 883841
Email: enquiries@c-cms.com
www.iptonline.com

Innovations in Pharmaceutical Technology (ISSN: 1471-7204, USPS No: 025082) is published four times a year – March, June, September, and December – by Samedan Ltd.

The opinions and views expressed by the authors in this book are not necessarily those of the Editor the Publisher and, while every care has been taken in the preparation of the book, the Editor and the Publisher are not responsible for such opinions and views or for
any inaccuracies in the articles.

The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred.

The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form, by any means – electronic,
mechanical, photocopying, or otherwise – without the prior permission of the Publisher.

© 2024 Samedan Ltd
Pharmaceutical Publishers